Grave’s disease. Modern representations and distribution in the territory of the Republic of Sakha (Yakutia)
https://doi.org/10.25789/YMJ.2018.63.27
Abstract
The article presents historical and modern ideas about Graves’ disease (GD), new approaches in treatment and diagnostics and the results of studies of foreign and domestic scientists on the role of genetic factors in the development of GD. In the Republic of Sakha (Yakutia), the share of GD in the structure of endocrine pathology ranks 2.3%. The Arctic regions are in the first places by the frequency of occurrence of GD.
About the Authors
T. K. Sunkharylova
Yakut Science Centre of complex medical problems
Russian Federation
Russian Federation
Sunhalyrova Tat’yana Konstantinovna - junior researcher of the laboratory of hereditary pathology
Yakutsk
V. V. Dodokhov
Federal State Educational Institution of Higher Professional Education Yakutsk State Agricultural Academy; Yakut Science Centre of complex medical problems
Russian Federation
Russian Federation
Dodokhov Vladimir Vladimirovich – PhD; Senior Lecturer, Researcher of the laboratory of hereditary pathology
Yakutsk
N. I. Pavlova
Yakut Science Centre of complex medical problems
Russian Federation
Russian Federation
Pavlova Nadezhda Ivanovna - PhD, Temporary acting chief scientific officer - head of the laboratory of hereditary pathology
Yakutsk
Kh. A. Kurtanov
Yakut Science Centre of complex medical problems
Russian Federation
Russian Federation
Kurtanov Khariton Alekseevich - PhD, Chief Scientific Officer - Head of the Department of Molecular Genetics
References
1. Dedov I.I. Antigens HLA for diffuse toxic goiter / I.I. Dedov [et al.] // Problems of endocrinology. – 1991. – № 1. – р. 4-5.
2. Balabolkin M.I. Endocrinology: a textbook / M.I. Balabolkin. – 2 nd edition, revised and enlarged. – M.: Universum Publishing, 1998. – 416 р.
3. Effect of treatment with radioactive iodine on the course of endocrine ophthalmopathy // A.V. Dreval’ [et al.] / Clinical and experimental thyroidology. – 2007. – р. 33-40.
4. Gagarin V.I. Iodine deficiency diseases in the population of the Republic of Sakha (Yakutia) / V.I. Gagarin, M.A. Fedorova, L.K. Turkebaeva // Far Eastern Medical Journal. – 2002. – р. 88-90.
5. Dedov I.I. Endocrinology: national leadership. Short Edition / I.I. Dedov, G.A. Mel’nichenko. – M.: GEOTAR – Media, 2013. – 741 p.
6. From the experience of treatment of thyrotoxicosis with radioactive iodine / M.N. Sanches [et al.] // Ukrainian Radiological Journal. – 2012. – №3. – р. 324-326.
7. Kotova G.A. Diffuse toxic goiter / G.A. Kotova // Clinical Endocrinology. – 2002. – р. 131-150.
8. Krizhanovskaya E.V. The use of fixed activity of I-131 500 MBK in the treatment of patients with diffuse-toxic goiter / E.V. Krizhanovskaya, S.A. Nabokov // Achievements: Sat. Theses of the VII All-Russian Congress of Endocrinologists. FGBU «Endocrinology Research Center» of the Ministry of Health of Russia; Ministry of Health of the Russian Federation; Public organization «Russian Association of Endocrinologists». – 2016. – 282 p.
9. Latkina N.V. Prediction of outcomes of surgical treatment of diffuse toxic goiter based on clinical and immunological indicators / N.V. Latkina, N.S.Kuznecov, V.I. Kandror // IV Congress of Endocrinologists: Abstracts. – St. Petersburg, 2001. – 331 р.
10. Lezhnyov N.V. Goiter in Russia / N.V. Lezhnev. – M.: Printing house M. Borisenko, 1904. – 341 р.
11. Makarov I.V. Modern trends and our experience of DTG treatment / I.V. Makarov, R.A. Galkin, M.M. Andreev // Herald of SUSU. – 2010. – №4. – р.54-56.
12. On the relationship between the development of diffuse-toxic goiter of severe and moderate severity with the provision of the body with zinc / D.S. Vinichenko [et al.] // Postgraduate Doctor journal. – 2016. – №3. – р. 71-80.
13. Polozkova N.I. Clinico-laboratory, hormonal immunogenetic criteria of a choice of methods of treatment of autoimmune diseases of a thyroid gland: the dissertation of the candidate of medical sciences: specialization 14.00.03 / N.I. Polozkova. – М., 1990. – 136 р.
14. Results of application of infusion ozonotherapy for diffuse-toxic goiter / E.G. Logacheva [et al.] // Health Care in Kyrgyzstan. – 2012. – №5. – р.49-50.
15. HLA system: structure, functions, obvious and possible connection with autoimmune and atopic diseases / E.V. Semin [et al.]// лечебное дело. – 2012. – р. 4-9.
16. Trukhina L.V. Immunological, genetic and morphological markers of forecasting of surgical treatment of diffuse toxic goiter: the dissertation of the candidate of medical sciences specialization14.00.03. /L.V. Trukhina. – M., 2006. – 141 p.
17. Surgical tactics of treating diffuse-toxic goiter / F.A. Daminov [et al.] // Academic Journal of Western Siberia. – 2013. – №1. – р. 21.
18. Shabalin V.I. Clinical Immunohematology / V.I. Shabalin, L.D. Serova // Medicine. – 1988. – р.83-87.
19. Endocrine diseases as a medical and social problem of our time / E. V. Kuznetsov [et al.] // Modern problems of science and education. – 2017. – № 4.
20. A novel and major association of HLA-C in Graves’ disease that eclipses the classical HLADRB1 effect / M.J. Simmonds [et al.] // Hum. Mol. Genet. – 2007. – Vol. 16. – P.2149–2153.
21. Dissecting the Genetic Susceptibility to Graves’ disease in a Cohort of Patients of Italian Origin / A. Lombardi [et al.] // Front Endocrinol. – 2016. – Vol. 8.
22. Does early administration of thyroxine reduce the development of Graves’ ophthalmopathy after radioiodine treatment / L. Tallstedt [et al.] // Eur. J. Endocrinol. – 1994. – Vol. 130. – P.494–497.
23. Gough S.C. The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action / S.C. Gough, M.J. Simmonds // Curr. Genomics. – 2007. – Vol. 8(7). – P. 453-465.
24. Hemithyroidectomy plus contralateral resection or bilateral resection? A prospective randomized study of postoperative complication and long-term results / L. Andaker [et al.] // World J. Surg. 1992. – Vol. 16. – P. 765 – 769.
25. HLA class I and II antigens in South African blacks with Graves’ disease / M.A. Omar [et al.] // Clin. Immunol. Immunopathol. – 1990. – Vol. 54. – P. 98–102.
26. Jacobson E.M. The genetic basis of thyroid autoimmunity / E.M. Jacobson, Y. Tomer // Thyroid. – 2007. – Vol. 17(10). – P. 949-961.
27. Kisielow P. Development and selection of T cells: facts and puzzles / P. Kisielow, H. Boehmer // Adv. Immunol. – 1995. – Vol. 58. – P. 87-209.
28. Long-tern follow up after antihiroid drug treatment in Grave’s diseasу / T. Wille [et al.] // Rundsh. Med. Prax. – 2006. – Vol. 95. – P. 1121- 1127.
29. Marcocci C.The course of Graves’ ophthalmopathy is not influenced by near total thyroidectomy / C. Marcocci, G. BrunoBossio, L. Manetti // Clin. Endocr. – 1999. – Vol.51. – P.503– 508.
30. Simmonds M.J. Unraveling the genetic complexity of autoimmune thyroid disease: HLA, CTLA-4 and beyond / M.J. Simmonds, S.C. Gough // Clin Exp Immunol. – 2004. – Vol. 136(1). – P. 1-10.
31. Wiersinga W.M. Preventing Graves’ ophthalmopathy / W.M. Wiersinga // N. Engl. J. Med. – 1998. – Vol. 338. – P. 121–122.
Review
For citations:
Sunkharylova T.K., Dodokhov V.V., Pavlova N.I., Kurtanov Kh.A. Grave’s disease. Modern representations and distribution in the territory of the Republic of Sakha (Yakutia). Yakut Medical Journal. 2018;(3):80-83. https://doi.org/10.25789/YMJ.2018.63.27
Views:
4
Email this article 